Health Notes is an occasional listing of health happenings around Louisiana. Have something you'd like to share? Contact us at margaret.delaney@theadvocate.com.

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

In this study, researchers aimed to fill gaps in the knowledge of treatment management and outcomes in melanoma patients aged 75 years and older.

The study explores the neoadjuvant approach: administering the immunotherapy drug Keytruda (pembrolizumab) before a surgeon ever picks up a scalpel. Researchers observed dramatic tumor shrinkage and, ...

For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment ...

BALTIMORE, MD. (Ivanhoe Newswire) - Melanoma, which affects the skin, is one of the most common and serious cancers in the U.S. It can be life-threatening in as little as six weeks. Its tumors can be ...

LAG-3 and TIGIT expression may predict skin melanoma progression and survival. Discover how these immune markers could shape future therapies. Read more.

Clinical utility may be greatest with careful patient selection, given frailty-associated toxicity and potential endpoint inflation in indolent tumors, warranting larger validation cohorts and ...

Teddi Mellencamp has shared a sobering update on her health. On April 2, The Real Housewives of Beverly Hills alum said in an emotional Instagram video that she now has stage IV cancer. Mellencamp was ...

MURRAY — Intermountain Medical Center recently became one of the first medical centers in Utah to offer a genetically personalized skin cancer treatment option for those with advanced melanoma.